Search Results
(
)
Filter by
Filter by health areas, people and populations, or solutions
Filter by EGPAF’s stories, research, resources or news
Poster
Twenty-Four-Month Survival Among Patients with Cryptococcal Antigenemia Enrolled in Malawi’s Advanced HIV Disease Program: A Retrospective Cohort Study
Published August 10, 2026
We assessed 24-month survival and factors associated with mortality among AHD clients with cryptococcal antigenemia enrolled in Malawi’s AHD program.
Topics:
Advanced HIV Disease (AHD)
Countries:
Malawi